Skip to content
Late-StageResearch compoundModerate evidence

Tropisetron

Prescription anti-nausea drug also researched as a nootropic and neuroprotectant; that use is still experimental.

NootropicAnti-inflammatoryCholinergicNeuroprotectionMemoryMood SupportAnxiolyticAcetylcholineSerotoninDopamine

Pharmacology

ClassCholinergic · Neuroprotection · Memory · Mood Support · Anxiolytic
Primary targetAlpha-7 nicotinic receptor partial agonist
Targets4 receptor targets
Half-lifeAbout 6-8 hours in normal metabolizers, substantially longer in poor CYP2D6 metabolizers
OnsetWithin a few hours orally; typically dosed once daily
EvidenceModerate evidence
Affected systemsAcetylcholineSerotoninDopamine

Contents

DETAILED OVERVIEW

What is Tropisetron?

Tropisetron is a prescription anti-nausea medicine (Navoban), approved for nausea caused by chemotherapy and surgery in several EU member states and other countries; it has not been approved in the USA. Its use as a nootropic, that is, as a substance supporting brain performance, is experimental and off-label.

Its anti-nausea effect is based on blocking a nausea-triggering serotonin signal. It also partially activates a nicotine-sensitive receptor (a signal-receiving protein) in the brain that plays a role in memory, filtering of sensory input and calming inflammation. In a short human study in schizophrenia it improved the filtering of auditory stimuli and some thinking problems. In animal studies it showed neuroprotective and anti-inflammatory effects. Its most common side effect is headache; it can lengthen the QT interval, that is, cause a change in heart rhythm. It is contraindicated in congenital long QT syndrome, and its safety in pregnancy and breastfeeding has not been shown.

Mechanism

5-HT3 antagonist + α7 nicotinic partial agonist

Half-life

~6-8 h (longer in poor metabolizers)

Legal status

Rx antiemetic (EU; not FDA-approved)

Receptor profile

  • Alpha-7 nicotinic acetylcholine receptor (α7 nAChR)Strong
  • Serotonin 5-HT3 receptor (antagonist)Strong
  • Beta-amyloid (experimental neuroprotection)Moderate
  • Dopamine (dose-dependent)Weak

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Headache, the most common antiemetic side effect
  • Constipation and digestive discomfort
  • Dizziness, drowsiness or fatigue
  • QT prolongation and heart-rhythm changes, especially at high doses or with other QT-prolonging drugs
  • Rarely abdominal pain, diarrhea or transient blood-pressure changes

Contraindications · 5

  • Pregnancy and breastfeeding: safety not adequately established, avoid
  • Congenital long QT syndrome, arrhythmia or concurrent use of other QT-prolonging drugs
  • Known hypersensitivity to tropisetron or other 5-HT3 antagonists
  • Poor CYP2D6 metabolizers: elevated plasma levels and prolonged exposure
  • Prescription medicine, not recommended as a nootropic without medical supervision

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Tropisetron is a prescription antiemetic medicine, approved mainly to prevent nausea from chemotherapy and surgery. Researchers have also looked at its effects on the brain: short human studies found it improved certain attention-related cognitive measures in schizophrenia, and animal studies showed anti-inflammatory, nerve-protective and pain-reducing effects, but those cognitive and brain-protective uses are still experimental.

Telegram

Have a question about Tropisetron?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC17H20N2O2
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.